More on Monsanto's (MON) FQ4 results: In addition to missing its EPS and revenue numbers, MON...

|About: Monsanto Company (MON)|By:, SA News Editor

More on Monsanto's (MON) FQ4 results: In addition to missing its EPS and revenue numbers, MON issues downside guidance for FY 2013, seeing EPS of $4.18-$4.32 vs. $4.37 analyst consensus. For FY 2012, Seeds and Genomics sales were $9.8B, a 14% increase Y/Y; FQ4 sales in the segment were $1.2B, 10% lower Y/Y. MON -3.1% premarket.